Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03006978 · ClinicalTrials.gov registry record · NA

A Pilot Study of the TearCare System in Adults With Dry Eye Disease

A NA study, sponsored by Sight Sciences.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT03006978: Completed NA study, sponsored by Sight Sciences.

NCT03006978 is a NA study that has completed, run by Sight Sciences. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03006978, a NA study, has completed, sponsored by Sight Sciences.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

This is a small, pilot study intended to determine the feasibility of this product.

Primary Outcome

The TBUT was evaluated by measuring the time to breakup of the tear film following a complete blink when viewed through the slit-lamp using a cobalt blue filter. The TBUT was recorded using a stopwatch for each eye as the average of 3 measurements at each visit. The change in TBUT was The difference between the mean baseline value and the mean Month 1 value. The TBUT for each eye for a subject was averaged. An increase in TBUT represents an improvement.

Interventions

  • DEVICE TearCare
  • DEVICE Warm Compress

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2017-01
Est. Completion 2018-03
Phase NA
Sight Sciences

14 total trials

What the finished NCT03006978 record still lists

NCT03006978 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which TearCare is the first listed.

NCT03006978 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03006978 about?

NCT03006978 is a clinical study titled "A Pilot Study of the TearCare System in Adults With Dry Eye Disease". This is a small, pilot study intended to determine the feasibility of this product.

What is the current status of trial NCT03006978?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2017-01. Estimated completion is 2018-03.

What interventions are being tested in trial NCT03006978?

The interventions under investigation include: TearCare (DEVICE), Warm Compress (DEVICE).

Who is sponsoring clinical trial NCT03006978?

This trial is sponsored by Sight Sciences, which has 14 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03006978's enrollment target sits among peer trials

24 1736th of 2000 higher than 246 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03006978, the US trial registry maintained by the National Library of Medicine. NCT03006978 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.